Unique ID issued by UMIN | UMIN000000631 |
---|---|
Receipt number | R000000765 |
Scientific Title | Multicenter phase III study of antimicrobial prophylaxis in low-risk patients undergoing distal gastrectomy for gastric cancer (OGSG 0501) |
Date of disclosure of the study information | 2007/04/01 |
Last modified on | 2021/11/15 22:19:20 |
Multicenter phase III study of antimicrobial prophylaxis in low-risk patients undergoing distal gastrectomy for gastric cancer (OGSG 0501)
OGSG-0501
Multicenter phase III study of antimicrobial prophylaxis in low-risk patients undergoing distal gastrectomy for gastric cancer (OGSG 0501)
OGSG-0501
Japan |
distal gastrectomy for gastric cancer
Infectious disease | Gastrointestinal surgery | Operative medicine |
Nursing |
Malignancy
NO
We examine whether AMP before and during surgical operation has the same effect as AMP administered for 3 to 4 days, postoperatively, by a phase III study on SSI.
Safety
Confirmatory
Pragmatic
Phase III
Incidence of SSI
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Dose comparison
YES
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Medicine |
Group A: AMP is administered before and during surgical operation and SSI is detected after surgery.
Group B: AMP is administered before, during and after surgical operation and SSI is detected after surgery.
Not applicable |
Not applicable |
Male and Female
1.age not limmited.
2.histologically proven gastric cancer
3.ASA score of 1 or 2
4.completion of written informed consent
5.distal gastrectomy with D2 lymphadenectomy and clean-contaminated operation
1.with some active or uncontrolled infection
2.neoadjuvant chemotherapy
3.PS>3 in ASA
4.administration of steroids
5.decision of ineligible patients by the researcher
342
1st name | |
Middle name | |
Last name | Hiroshi Imamura |
Toyonaka City Hospital
Dpt.Surgery
4-14-1, shibaharacho, Toyonka City, Osaka, Japan, 560-8565
06-6843-0101
imamurahiroshisakai@yahoo.co.jp
1st name | |
Middle name | |
Last name | Hiroshi Imamura |
Toyonaka City Hospital
Dpt.Surgery
4-14-1, shibaharacho, Toyonka City, Osaka, Japan, 560-8565
06-6843-0101
imamurahiroshisakai@yahoo.co.jp
Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)
Osaka Clinical Study Supporting Organization
Self funding
NO
2007 | Year | 04 | Month | 01 | Day |
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(11)70370-X/fulltext
Published
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(11)70370-X/fulltext
355
Eight patients (5%, 95% CI 2-9%) had surgical-site infections in the intraoperative group compared with 16 (9%, 5-14) in the extended group. The relative risk of surgical-site infections with intraoperative antimicrobial prophylaxis was 0.51 (0.22-1.16), which revealed statistically significant non-inferiority (p<0.0001).
2021 | Year | 11 | Month | 14 | Day |
2012 | Year | 01 | Month | 31 | Day |
Patients with gastric cancer that was potentially curable with a distal gastrectomy
Between June 2, 2005, and Dec 6, 2007, 355 patients were randomly assigned to receive either intraoperative antimicrobial prophylaxis alone (n=176) or extended antimicrobial prophylaxis (n=179).
.
The primary endpoint was the incidence of surgical-site infections.
Completed
2005 | Year | 02 | Month | 08 | Day |
2005 | Year | 03 | Month | 01 | Day |
2008 | Year | 08 | Month | 01 | Day |
2009 | Year | 02 | Month | 01 | Day |
2009 | Year | 02 | Month | 01 | Day |
2009 | Year | 02 | Month | 01 | Day |
2007 | Year | 03 | Month | 07 | Day |
2021 | Year | 11 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000765